LEP and obesity due to melanocortin 4 receptor deficiency: Leptin administered either systemically or centrally increases sympathetic nerve activity to at least some target tissues (Dunbar et al., 1997; Haynes et al., 1997), and, with chronic administration sufficient to mimic leptin levels seen in obesity, can lead to increases in arterial pressure (Shek et al., 1998).